About this trial
The goal of this observational study is to evaluate infusion alarms, particularly air-in-line alarms, during antineoplastic drug infusion in oncology care settings.
The main questions it aims to answer are:
How frequently do infusion alarms occur, and what types of alarms are observed during antineoplastic drug infusion? How long does it take healthcare professionals to manage infusion alarms and restore infusion continuity? What strategies do healthcare professionals use to manage infusion alarms? How do healthcare professionals evaluate the user experience of different infusion technologies?
Participants will be healthcare professionals involved in antineoplastic drug infusion. They will not receive any experimental intervention. Researchers will observe routine infusion procedures and collect data on alarm events, alarm management, infusion technologies, and user experience.
Eligibility criteria
Qualifiers
Healthcare professionals involved in the administration of antineoplastic drugs in participating oncology centres.
Employment in a participating study site during the study period.
Direct involvement in routine intravenous antineoplastic drug infusion procedures.
Participation in infusion procedures eligible for observation according to the study protocol.
Disqualifiers
Healthcare professionals not directly involved in antineoplastic drug administration.
Healthcare professionals working outside participating study sites.
Temporary staff not routinely involved in infusion activities during the observation period.
Refusal to participate in study activities where local regulations require participant notification.
Trial design
Treatments tested in this trial
- Routine Infusion Technologies
Treatment groups
Sponsors and collaborators
Associazione Italiana Infermieri di Area Oncologica
Lead sponsor
IRCCS Multimedica
Collaborator
University of Milan
Collaborator